HIDRADENITIS SUPPURATIVA
DOI:
https://doi.org/10.35120/medisij010243sKeywords:
hidradenitis suppurativa, pathology, stage, treatmentAbstract
Hidradenitis suppurativa (HS), or still known under the name Acne Inversa is a multifactor disease that has a chronic flow and starts with the capture of follicles of fibers located in intertriginous regions or anogenital regions. It is followed by recurrent, deep, sub connected and painful nodes, connected intertriginous sinus tracts and hypertrophic scars. Women are more versatile from men, according to 3:1 and more likely to develop axillary and genitofemoral lesions than a male population that develops changes that are localized in the perineal region. The disease itself is unpredictable flow and cannot be certain whether the period of menstruation, pregnancy or menopause may affect the deterioration of the patient’s condition. Usually, the bacterial infection that builds on the state itself is like a secondary phenomenon and most often isolate beta hemolytic streptococcus or staphylococcus. The pathogenesis of the disease is still unclear, but it is thought that the primary event that occurs is follicular occlusion occurring as a result of infundibular keratosis and epithelial hyperplasia. Features show that patients say that the same changes occur in other members of the family. Some genes from Secretase G family are thought to be responsible for the disease itself. On the other hand, there are autoimmune reasons for the very disease, both of the innate and the acquired immunity. However, this disease is classified as neutrophilic restriction. The simplest and most widely used instrument for HS classification in routine clinical practice. It classifies HS into three stages: Stage I: isolated, single or more painful abscesses, no scars and occurrence of cicatrix. Stage II: recurrent pain abscesses with scars, single or multiple but not so extensive. Stage III: diffuse, similar to plates, inflammatory, sick infiltrates or more mutual abscesses. Contracts of joints as a result of limited mobility associated with pain. Because the disease has more stages and treatment itself will be correlated with the stage of the disease. We should emphasize that the disease can also be worsened by some accompanying diseases from which the type 2 diabetes or some other endocrine and metabolic diseases should be distinguished in the first place. Always put the lifestyle and change in everyday habits as it is in the first place to reduce weight if it is increased as well as the cancellation of cigarette smoking. Primary in treatment is maintaining good personal hygiene with soaps that are antibacterial and pastures with mild disinfection. At the beginning of the disease, antibiotics are usually attached as local and systemic administration, most often from the group of tetracyclines. Anti-inflammatory preparations are given in order to reduce inflammation and drug reduction drugs. As antiseptics use salicylic solution, alcohol pine, camphor, ethyl alcohol or iodine. More recently, it goes to make drinks from iodine and potassium hypermangan. If it is not contraindicated, corticosteroid creams and gels as well as a local anesthetic can be reduced. Surgical intervention can be applied to make an incision of a nodule or an apex to be easier drainage and thus reduced the pain of the region concerned. It should be noted that this disease affects the whole family. In the first place, it is necessary to accept the patient’s patient in order not to isolate it from the rest and to participate in social life as before the disease itself. A conversation is necessary by a psychologist with the whole family in order to facilitate life and improve the quality of it.
Downloads
References
Klaus W., & Richard A. J. (2009). Fitzpatricks Color Atlas & Synopsis of Clinical Dermatology. 6th edition. Mc Graw Hill.
Klaus W., Richard A. J. , & Arturo S. (2014). Fitzpatricks Dermatology Flash Cards. 1st edition. Mc Graw Hill
Gerd P., Lars F., Thomas R . , Roland K . , & Micheal H. (2022). Braun-Falco’s Dermatology. 4th edition. Springer
Lawrence S. C., & Vivian Y. S. (2022). Atopic Dermatitis: Inside Out Or Outside In. 1st edition. Elsevier
Bruce H. T., & Kelly M. C. (2022). Pediatric Dermatology Part II, An Issue of Dermatologic Clinics. 1st edition. Elsevier
Francesca S., Micheal T., Uwe W., & Torello M. L. (2022). Clinical Cases in Pediatric Skin Cancers. 1st edition. Springer
Vivian Y. S., Jennifer L. H., Michelle A. L., Iltefat H. H. (2021). A Comprehensive Guide to Hidradenitis Suppurativa. 1st edition. Elsevier
Reid A. W., & Jane M. G. K. (2021). Dermatology for the Primary Care Provider. 1st edition. Elsevier
James G. H. D. (2020). Habif’s Clinical Dermatology. 7th edition. Elsevier
Amy S. P., & Anthony J. M. (2020). Hurwitz Clinical Pediatric Dermatology. 6th edition. Elsevier
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 MEDIS – International Journal of Medical Sciences and Research
This work is licensed under a Creative Commons Attribution 4.0 International License.